Events
December 2021: 2nd scientific day of BETPSY
Wednesay 1st december, members from the BETPSY project presented their work and results. The project is progressing very well and all the consortium was happy to share this moment. We would like to thank all of you for your support, the SAB member for all the advices and of cours all the scientiifcs who have presented.
August 2021 - Neurodis Project
The proposed Neurodis project From St Etienne/INMG team has almost reached its goal. This will help us finding autoantibodies as diagnostic blood biomarkers for patients with neuropathies.
June 2021- ISNI Nice congress
Join and be part of the NeuroImmunology community!
SNI has decided to go virtual with the ISNI 2021 Congress set for November 8-12 and take advantage of all the possibilities a virtual meeting can offer
May 2025 - Editorial commentary
This article hilights the work of 19 experts from 8 coutries who updated the diagnostic criteria for paraneoplastic neurologic syndromes to enhance the clinical care of patients and to encourage standardization of PNS research initiatives.
April 2021 - Editorial commentay
This editorial calls attention to Marini et al work which reviews the scope of ICI-associated neurologic irAEs reported so far. The review summarizes the acute and subacute events surrounding ICI-associated neurologic irAEs, but detailed long-term outcomes were not consistently available.
January 2021 - 1st Scientific day of BETPSY
On wednesday 13th, took place the scientific day of BETPSY virtually. Recherch teams and our industrial partner Euroimmun, presented their work as well as the progress. All BETPSY members would like to thank the speakers, attendees and member of the SAB for their support.
October 2020 - Twitter news Logo Twitter
An interesting paper from one of our epileptologist follower on twitter was suggested. It explains how should be considered epileptic seizures assiocated with surface antibodies.
October 2020 - Encephalitis Conference december 2020
The Encephalitis Conference is dedicated exclusively to encephalitis and covers epidemiology, pathogenesis, diagnosis, treatment and rehabilitation in both children and adults, covering both infectious and autoimmune aetiologies.
July 2020 - Editorial commentary
This editorial commentary presents the work of Muñiz-Castrillo and al. concerning precision medicine in CASPR2-antibody diseases by dissecting clinical features, serology and genetics across 56 patients.
July 2020 - AE Newsletter
The AE alliance has dedicated this quarterly newsletter to spotlighting important research initiatives and advancements for honoring and supporting devoted physicians and scientists working to improve Patient's life with AE.
June 2020 - Editorial commentary
This article hilights the research work of Vogrig and al about the differences between encephalitis as an immune-related adverse event versus encephalitis in regular clinical practice.
